HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 7, Issue 2, 2011, Pages 193-200

  Wang, Yuhua ^a   Canine, Brenda F ^a   Hatefi, Arash ^a,b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Cancer therapy; Gene delivery; Nonviral; Recombinant vector; Suicide gene

Indexed keywords

CANCER THERAPY; GENE DELIVERY; NONVIRAL; RECOMBINANT VECTOR; SUICIDE GENE;

CELLS; DISEASES; ENZYMES; GENE TRANSFER; ONCOLOGY; TUMORS; VECTORS;

GENE THERAPY;

GANCICLOVIR; LIPOFECTAMINE; NANOPARTICLE; SITIMAGENE CERADENOVEC; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; FEMALE; GENE TARGETING; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PARTICLE SIZE; RECOMBINANT PLASMID; SUICIDE GENE; SUICIDE GENE THERAPY; TREATMENT OUTCOME; TUMOR VOLUME; TUMOR XENOGRAFT; ZETA POTENTIAL;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC PROTOCOLS; ANTIVIRAL AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; GANCICLOVIR; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; HUMANS; MICE; MICE, NUDE; NANOMEDICINE; NANOPARTICLES; PRODRUGS; THYMIDINE KINASE; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

SIMPLEXVIRUS;

EID: 79952774766     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2010.08.003     Document Type: Article

References (25)

1. Goparaju G.N., Satishchandran C., Gupta P.K. The effect of the structure of small cationic peptides on the characteristics of peptide-DNA complexes. Int J Pharm 2009, 369:162-169.
2. Keller M., Harbottle R.P., Perouzel E., Colin M., Shah I., Rahim A., et al. Nuclear localisation sequence templated nonviral gene delivery vectors: investigation of intracellular trafficking events of LMD and LD vector systems. Chembiochem 2003, 4:286-298.
3. Ludtke J.J., Zhang G., Sebestyen M.G., Wolff J.A. A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. J Cell Sci 1999, 112(Pt. 12):2033-2041.
4. Mangipudi S.S., Canine B.F., Wang Y., Hatefi A. Development of a genetically engineered biomimetic vector for targeted gene transfer to breast cancer cells. Mol Pharm 2009, 6:1100-1109.
5. Rajagopalan R., Xavier J., Rangaraj N., Rao N.M., Gopal V. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery. J Gene Med 2007, 9:275-286.
6. Xavier J., Singh S., Dean D.A., Rao N.M., Gopal V. Designed multi-domain protein as a carrier of nucleic acids into cells. J Control Release 2009, 133:154-160.
7. Canine B.F., Wang Y., Hatefi A. Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells. J Control Release 2009, 138:188-196.
8. Wang Y., Mangipudi S.S., Canine B.F., Hatefi A. A designer biomimetic vector with a chimeric architecture for targeted gene transfer. J Control Release 2009, 137:46-53.
9. McCarthy H.O., Wang Y., Mangipudi S.S., Hatefi A. Advances with the use of bio-inspired vectors towards creation of artificial viruses. Expert Opin Drug Deliv 2010, 7:1-16.
10. Mahan S.D., Ireton G.C., Knoeber C., Stoddard B.L., Black M.E. Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy. Protein Eng Des Sel 2004, 17:625-633.
11. Chu Q.D., Sun L., Li J., Byrnes K., Chervenak D., DeBenedetti A., et al. Rat adenocarcinoma cell line infected with an adenovirus carrying a novel herpes-simplex virus-thymidine kinase suicide gene construct dies by apoptosis upon treatment with ganciclovir. J Surg Res 2007, 143:189-194.
12. Fischer U., Steffens S., Frank S., Rainov N.G., Schulze-Osthoff K., Kramm C.M. Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. Oncogene 2005, 24:1231-1243.
13. Kagawa S., He C., Gu J., Koch P., Rha S.J., Roth J.A., et al. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 2001, 61:3330-3338.
14. Norris J.S., Hyer M.L., Voelkel-Johnson C., Lowe S.L., Rubinchik S., Dong J.Y. The use of Fas ligand, TRAIL and Bax in gene therapy of prostate cancer. Curr Gene Ther 2001, 1:123-136.
15. Qiao J., Black M.E., Caruso M. Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant. Hum Gene Ther 2000, 11:1569-1576.
16. Freytag S.O., Stricker H., Movsas B., Kim J.H. Prostate cancer gene therapy clinical trials. Mol Ther 2007, 15:1042-1052.
17. Black M.E., Kokoris M.S., Sabo P. Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing. Cancer Res 2001, 61:3022-3026.
18. Kokoris M.S., Black M.E. Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity. Protein Sci 2002, 11:2267-2272.
19. Franken N.A., Rodermond H.M., Stap J., Haveman J., van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006, 1:2315-2319.
20. Culver K.W., Ram Z., Wallbridge S., Ishii H., Oldfield E.H., Blaese R.M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992, 256:1550-1552.
21. Rainov N.G. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 2000, 11:2389-2401.
22. Sterman D.H., Treat J., Litzky L.A., Amin K.M., Coonrod L., Molnar-Kimber K., et al. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma. Hum Gene Ther 1998, 9:1083-1092.
23. Fuchita M., Ardiani A., Zhao L., Serve K., Stoddard B.L., Black M.E. Bacterial cytosine deaminase mutants created by molecular engineering show improved 5-fluorocytosine-mediated cell killing in vitro and in vivo. Cancer Res 2009, 69:4791-4799.
24. Rejman J., Oberle V., Zuhorn I.S., Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 2004, 377(Pt. 1):159-169.
25. Wiewrodt R., Amin K., Kiefer M., Jovanovic V.P., Kapoor V., Force S., et al. Adenovirus-mediated gene transfer of enhanced herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing. Cancer Gene Ther 2003, 10:353-364.